HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 9.000
- +0.480+5.63%
Trading Feb 18 11:50 ET
765.58MMarket Cap-16.36P/E (TTM)
9.200High8.520Low511.67KVolume8.520Open8.520Pre Close4.58MTurnover0.62%Turnover RatioLossP/E (Static)85.06MShares14.44152wk High6.90P/B742.27MFloat Cap3.25052wk Low--Dividend TTM82.47MShs Float31.500Historical High--Div YieldTTM7.98%Amplitude0.600Historical Low8.948Avg Price1Lot Size
Anavex Life Sciences News
Anavex Life Sciences | 10-Q: Q1 2025 Earnings Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 10-K: FY2024 Annual Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 10-Q: Q3 2024 Earnings Report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | S-3: Registration statement for specified transactions by certain issuers
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 10-Q: Q2 2024 Earnings Report
Anavex Life Sciences | 8-K: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
Anavex Life Sciences | DEF 14A: Definitive information statements
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!